Pillstats
Rx only · Suspension · Oral

Tadalafil

Brands: Tadliq · Tadalafil

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCG04BE08
RxCUI (US)358263
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.76$7.51$11.27$15.02Oct 2025Jul 2026Jul 2026
$13.064
Latest avg · Jul 22, 2026
+2%
Since Oct 1, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.2K2.3K3.5K4.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.1K
Rx · 2026 Q1
526K
Units dispensed
+23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
CMP Pharma, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.